Co-founder & CEO
30+ years in biopharma & healthcare, focusing on R&D management, B2B partnerships and value creation strategy. Has engaged with over 100 organizations in biopharma, medical technology and healthcare. Published authority on biopharma R&D partnerships and biotech business models
CHIEF TECHNOLOGY OFFICER
Deep technical capabilities, strong academic network and author of multiple scientific papers on system biology modeling of cardiometabolic diseases. Most recent prior role was leading a data science team at a Boston-based biotech that was acquired for >$2 billion
CHIEF SCIENCE OFFICER
Forbes 30 under 30. Founded The Longevity Labs, whose nutraceutical is now marketed in >14 countries including USA, exited after 3 years. Leadership experience with two other startups in cancer genomics and AI-enabled robotics.
Celia Antonio Schell
VP STUDY & PARTNERSHIP OPERATIONS
14 years experience in clinical research at Novartis and ICON. Recently managed a global Phase III clinical trial of >7,000 cardiovascular patients across 43 countries.
Lead DATA SCIENTIST
Accomplished systems biology modeler. Most recently at the European Bioinformatics Institute. Prior to this, conducted academic research including journal papers on systems biology modeling of atherosclerosis.
CHIEF OF STAFF & FINANCE MANAGER
Broad experience base of international collaborative activities. Product manager in a B2B financial data & solutions provider. Project manager in an energy & fintech business. Founded & exited own business.
Experienced at analyzing and interpreting multi-omic patient and in vitro/in vivo data. Previously in the translational medicine data science team at Benevolent AI.
BUSINESS DEVT. & ALLIANCE MGMT.
Analyst working across the bioscience and business interface with Master’s degree in Bioscience Entrepreneurship and Bachelor’s degree in biochemistry. Previous experience working in a range of healthcare-centred roles, spanning project support in primary care training to life sciences public relations
PARTNERSHIPS & CORPORATE DEVT.
Analyst working at the cross-section of business and bioscience, with an MSc in Bioscience Entrepreneurship and a BSc in Biomedical Sciences. Prior experience includes working in bioscience SMEs across marketing and business development functions, as well as pharmaceutical R&D
Experienced at analyzing high-dimensional omics datasets and building bioinformatics pipelines. Previously a postdoc at Imperial College London.
SCIENCE & BUSINESS ANALYST
Previously interned at Immunocore, AstraZeneca and the Wellcome Sanger Institute.
Starting Jan '24
LEAD DISEASE BIOLOGIST
SCIENTIFIC ADVISORY BOARD
Dr. Angeli Möller
ROCHE PHARMACEUTICALS DIVISION, SWITZERLAND
Head of Pharma International Informatics
Alliance for Artificial Intelligence in Healthcare (AAIH) EXECUTIVE OFFICER & CO-FOUNDER
Prof. Manuel Mayr
British Heart Foundation Professor of Cardiovascular Proteomics
KING'S COLLEGE LONDON, UK
CHIEF SCIENTIFIC OFFICER
director of biology
Want to be a part of our team?
Got a partnership in mind?
Get in touch with us and know more about how we are changing the face of healthcare.
Multiomic Health Limited is a registered UK company